Status: 04/07/2021 7:40 p.m.
After several countries restricted the use of AstraZeneca’s corona vaccine, only those over 30 years of age should be vaccinated with the agent in Great Britain.
In Great Britain, too, there is now a separate recommendation for the use of the AstraZeneca vaccine. The UK Vaccination Commission said 18-29 year olds should be given a different vaccine than AstraZeneca’s if possible. However, the Vaccination Commission underlined that it does not recommend a general stop of AstraZeneca vaccinations for certain age groups.
79 cases of rare blood clots in 20 million vaccinations
The UK Medicines Agency MHRA stressed that the benefits of vaccination with AstraZeneca outweigh the risks for most citizens, but it now seems likely that a connection between vaccination with this vaccine and a very rare blood clot is considered likely.
According to the MHRA, there have been over 20 million vaccinations with AstraZeneca in the UK to date. At the same time, 79 cases of rare blood clots were known by the end of March. 19 victims died, three of them were under 30.
In addition to AstraZeneca and Pfizer / BioNTech, Moderna is also vaccinated in Great Britain. AstraZeneca is the main vaccine in the UK vaccination program. Developed by Oxford University and the British-Swedish company AstraZeneca, it is the cheapest corona vaccine on the market. Many countries depend on the vaccine for their vaccination campaigns.
Great Britain changes vaccination strategy
Sven Lohmann, ARD London, daily topics 10:15 p.m., 7.4.2021
EMA reiterates vaccine assessment
Due to the isolated occurrence of thrombosis, several countries, including Germany, France and Canada, had restricted the use of the AstraZeneca vaccine. Other countries such as Denmark and Norway suspended its use completely as a precaution. The EU Medicines Agency (EMA) has now confirmed its positive assessment of the AstraZeneca corona vaccine.
Scientists have several theories about how clots can develop after the AstraZeneca drug is administered. A possible connection to the use of the contraceptive pill is also investigated. Experts emphasize that Covid-19 itself can trigger thrombosis, as can many common drugs, including the birth control pill. AstraZeneca had repeatedly stated that studies had not shown an increased risk of thrombosis.
With information from Imke Köhler, ARD-Studio London.
An alternative to AstraZeneca is to be offered to under 30-year-olds
Imke Köhler, ARD London, 7.4.2021, 9:18 p.m.